AMSTERDAM, Netherlands and SANTA CLARA, California, April 22 /PRNewswire/ Agendia BV, a world leader in the rapidly evolving field of molecular diagnostics, and Agilent Technologies, Inc. (NYSE: A), today announced terms under which they intend to collaborate to develop new in-vitro diagnostic tests.